1. Home
  2. REGN vs GWW Comparison

REGN vs GWW Comparison

Compare REGN & GWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$656.01

Market Cap

68.8B

Sector

Health Care

ML Signal

HOLD

Logo W.W. Grainger Inc.

GWW

W.W. Grainger Inc.

HOLD

Current Price

$1,382.60

Market Cap

64.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
REGN
GWW
Founded
1988
1927
Country
United States
United States
Employees
15410
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
68.8B
64.7B
IPO Year
1995
1994

Fundamental Metrics

Financial Performance
Metric
REGN
GWW
Price
$656.01
$1,382.60
Analyst Decision
Buy
Hold
Analyst Count
25
7
Target Price
$830.16
$1,118.14
AVG Volume (30 Days)
720.4K
268.0K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
0.55%
0.79%
EPS Growth
8.19
N/A
EPS
6.75
11.65
Revenue
$5,872,227,000.00
N/A
Revenue This Year
$12.45
$6.73
Revenue Next Year
$10.13
$6.90
P/E Ratio
$96.58
$117.38
Revenue Growth
20.82
N/A
52 Week Low
$541.00
$906.52
52 Week High
$821.11
$1,419.91

Technical Indicators

Market Signals
Indicator
REGN
GWW
Relative Strength Index (RSI) 52.60 56.59
Support Level $648.66 $1,316.72
Resistance Level $670.96 $1,405.44
Average True Range (ATR) 15.37 29.06
MACD -0.65 -4.56
Stochastic Oscillator 40.76 47.80

Price Performance

Historical Comparison
REGN
GWW

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

About GWW W.W. Grainger Inc.

Founded in 1927, W.W. Grainger originally distributed various motors via a mail-order catalogue. Over the course of the 20th century, the firm expanded into new industrial product categories and launched its first digital catalogue in 1995. Today, the company organizes itself into two segments focused on different customer bases. Its larger segment, high-touch solutions, offers a vast array of maintenance, repair, and operations, or MRO, supplies and bespoke inventory management services to larger businesses. Its smaller segment, endless assortment, operates two online platforms, Zoro and MonotaRO, that offer comprehensive catalogues of MRO supplies to smaller businesses. Grainger has operations throughout the world but primarily generates sales within the US.

Share on Social Networks: